Janet Tien

Genentech, a Member of the Roche Group

Janet Tien is an Associate Regulatory Program Director in Pharma Technical Regulatory at Genentech, a Member of the Roche Group, where she coordinates and leads CMC regulatory submissions for innovative biologics from clinical development through marketing authorization and post-approval globally. Prior to this role, Janet led an in vivo pharmacology team responsible for preclinical research on oncology therapeutics. She is also active on teams that work to increase diversity, inclusion, and equity in the workplace. Janet joined Genentech in 2004 after receiving her Ph.D. in Cell and Developmental Biology from the University of California, Davis.